Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions
Academic Pediatrics
· Elsevier
Аннотация
Publication date: Available online 13 November 2026 Source: AACE Endocrinology and Diabetes Author(s): Aimen Iqbal, Tala Radaideh, Muneebuddin Syed
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Педиатрия, перинатология и детское здоровье»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions. // Academic Pediatrics. – URL: https://www.sciencedirect.com/science/article/pii/S3050915726002808?dgcid=rss_sd_all
Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions. Academic Pediatrics. https://www.sciencedirect.com/science/article/pii/S3050915726002808?dgcid=rss_sd_all
“Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions.” Academic Pediatrics.
@article{article2351,
title = {Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions},
journal = {Academic Pediatrics},
url = {https://www.sciencedirect.com/science/article/pii/S3050915726002808?dgcid=rss_sd_all}
}